Recently, a series of low to intermediate grades of soft tissue tumors showing recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes have been defined as a new entity with S100 and CD34 co-expression (without SOX-10 positivity) (1). This evidence concerns the gene CD34 and soft tissue neoplasm.